Impact BioMedical (AMEX:IBO) Stock, Quote.Headers.trade-ideas

Impact BioMedical

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.

Stock Movers

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AZEK

BTOG

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

New Oriental Education & Technology Group

GCTK

IMTE

LGHL

MGNX

MLGO

NVNI

RNAZ

RZLT

SGLY

SWIN

WINT

Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Stock,Market,Investments,Crashing,Market Down

Earnings

Equities

Eurozone

Commodities

Intraday Update

ALUR

TELA

VVPR

Dow Tumbles Over 400 Points; Nike Shares Dip After Q3 Results

AUID

BHAT

BNTC

INNV

MCVT

OUST

PNBK

PSTV

RVSB

TNMG

USAR

XHLD

Why Ouster Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Impact BioMedical Inc

International Bancshares Corporation - Common Stock

International Bancshares Corp

UNIVERSAL IBOGAINE INC by Universal Ibogaine Inc.

Universal Ibogaine Inc

INDUSTRIAL BK KOREA S/GDR by Industrial Bank of Korea

Industrial Bank of Korea

VanEck Robotics ETF

Legal

Press Releases

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

IPOs

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

Positioned for Growth: Impact BioMedical Inc.'s (NYSEAmerican: IBO) Push into Cancer and Immune Health

Impact BioMedical Inc. (NYSEAmerican: IBO): Targeting Chronic Diseases with Patented Breakthroughs

Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

Impact BioMedical Inc. to Present at The Microcap Conference

Health Care

Impact Biomedical Inc. Announces Acquisition of Celios®, "Protecting People, Plants, and Animals from the World's Most Dangerous Pathogens With Clean-Room Air Quality"

Contracts

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

Impact Biomedical Inc. Announcement Stock Activity/Pricing

PRPH

ALT5 Sigma

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

Alto Neuroscience

AN2 Therapeutics

Assertio Holdings

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Context Therapeutics

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Grace Therapeutics

Ikena Oncology

Opus Genetics

Iterum Therapeutics

NRX Pharmaceuticals

Nutriband

OptiNose

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

Scilex Holding

SCYNEXIS

Universe Pharmaceuticals Inc - Ordinary Shares

Universe Pharmaceuticals

Veru

Verrica Pharmaceuticals Inc. - Common Stock

Verrica Pharmaceuticals

Virpax Pharmaceuticals, Inc. - Common Stock

Virpax Pharmaceuticals

Ventyx Biosciences

Comments

Impact BioMedical

Impact BioMedical (AMEX:IBO) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga